Changes in the Effectiveness of State Medicaid Drug Program Cost-Containment Policies Following OBRA 1990

نویسندگان

  • WILLIAM J. MOORE
  • ETIENNE E. PRACHT
چکیده

Containment of Medicaid pharmaceutical drug program costs continues to be an important policy problem. Perhaps the most important policy of the past two decades with significant implications for Medicaid pharmaceutical drug programs was the Omnibus Budget Reconciliation Act (OBRA) of 1990. This study analyzes Medicaid drug spending data from 1985 to 1997 to determine how OBRA 1990 influenced the effectiveness of existing drug cost-containment policies and if the Act produced its anticipated cost savings. The descriptive evidence indicates that reductions in drug expenditure growth rates, following the passage of OBRA 1990, resulted from factors that are independent from that Act. Furthermore, the analytical evidence shows that changes in the effectiveness of major cost-containment policies (drug formularies, drug utilization review programs, and reimbursement rates) offset, at least in part, savings from the drug rebate program included in OBRA 1990. *William J. Moore received his doctorate from the University of Texas at Austin. He is currently the Gulf Coast Coca-Cola Distinguished Professor of Economics at Louisiana State University. His primary research areas are health economics and labor economics. He is the author or co-author of numerous articles, including “Drug Formulary Restrictions as a Cost-Cost-Containment Policy in the Medicaid Programs” (with Robert Newman), Journal of Law and Economics (April 1993) and “System-Wide Effects of Medicaid Retrospective Drug Utilization Programs” (with Karen Gutermuth and Etienne Pracht), Journal of Health Politics, Policy and Law (August 2000). Etienne E. Pracht is an Assistant Professor of Economics in the Department of Health Policy and Management at the University of South Florida. His primary research interests are health economics and applied econometrics. He is the author or co-author of several articles, including “Interest Groups and State Medicaid Drug Programs,” Journal of Health Politics, Policy and Law (February 2003). American Journal of Economics and Sociology, Vol. 66, No. 5 (November, 2007). © 2007 American Journal of Economics and Sociology, Inc.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Experience of a Medicaid nursing home entry cohort

Long-term care cost-containment policies have focused on reducing the numbers of persons entering nursing homes. To provide insight and background for such efforts, the authors studied the experience of Medicaid nursing home entry cohorts in three individual States. They found substantial interstate variation in rates of nursing home entry and subsequent patterns of discharge, suggesting the op...

متن کامل

Generic Drug Cost Containment in Medicaid: Lessons from Five State MAC Programs

In Medicaid, generic drug cost containment revolves around two programs: the Federal upper limit (FUL) program and State maximum allowable cost (MAC) programs. This article analyzes MAC programs in five States and finds considerable variation between these programs and the FUL program in both size and pricing aggressiveness. We conclude that expansion of existing MAC programs and creation of ne...

متن کامل

Outcomes of California's Medicaid cost-containment policies, 1981-84

In 1982, California enacted a package of tough Medicaid cost-containment measures. This article examines its effects on program expenditures through 1984 by enrollment group and service category. Total expenditures fell by 19 percent (or $656.5 million) after inflation. Expenditures per enrollee declined for almost every group, with enrollees on cash assistance taking the greatest reductions. A...

متن کامل

Medicaid payment rates for nursing homes, 1979-86

The issue of the cost containment effects of payment systems on per diem payments by Medicaid to nursing homes is addressed. Estimates of real payment rates as a function of broadly defined payment system classifications and economic and demographic variables using State-level data are presented. Little support for the notion that prospective payment systems substantially restrain payment rates...

متن کامل

Medicaid prescription drug coverage: state efforts to control costs.

This paper provides a brief summary of the Medicaid prescription drug benefit. It explains the mechanisms being used by states to control their prescription drug spending within the Medicaid program. The paper also highlights some of the concerns that have been expressed with these mechanisms and the litigation that has been initiated in several states as a result of these efforts. It takes a c...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2007